Synergy Asset Management LLC acquired a new position in shares of Arcosa, Inc. (NYSE:ACA – Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 61,052 shares of the company’s stock, valued at approximately $5,242,000. Arcosa makes up 0.9% of Synergy Asset Management LLC’s holdings, making the stock its 26th largest position. Synergy Asset Management LLC owned about 0.13% of Arcosa as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors also recently modified their holdings of the company. Criterion Capital Advisors LLC bought a new stake in Arcosa during the 4th quarter worth about $33,000. ICA Group Wealth Management LLC bought a new stake in shares of Arcosa during the fourth quarter valued at approximately $33,000. McGlone Suttner Wealth Management Inc. acquired a new stake in shares of Arcosa in the fourth quarter valued at approximately $36,000. Scarborough Advisors LLC bought a new position in Arcosa in the 4th quarter worth approximately $42,000. Finally, Quadrant Capital Group LLC lifted its holdings in Arcosa by 22.9% during the 4th quarter. Quadrant Capital Group LLC now owns 1,072 shares of the company’s stock worth $89,000 after buying an additional 200 shares in the last quarter. Institutional investors own 90.66% of the company’s stock.
Insider Transactions at Arcosa
In other news, insider Kerry S. Cole sold 10,978 shares of the stock in a transaction dated Wednesday, May 15th. The shares were sold at an average price of $88.71, for a total value of $973,858.38. Following the completion of the transaction, the insider now owns 18,527 shares of the company’s stock, valued at $1,643,530.17. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.20% of the stock is owned by insiders.
Arcosa Stock Performance
Arcosa (NYSE:ACA – Get Free Report) last issued its quarterly earnings results on Friday, May 3rd. The company reported $0.73 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.52 by $0.21. The business had revenue of $598.60 million during the quarter, compared to analysts’ expectations of $580.06 million. Arcosa had a return on equity of 6.13% and a net margin of 6.05%. The firm’s revenue for the quarter was up 9.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.06 earnings per share. Research analysts anticipate that Arcosa, Inc. will post 3.58 EPS for the current fiscal year.
Arcosa Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 31st. Stockholders of record on Monday, July 15th will be paid a $0.05 dividend. The ex-dividend date of this dividend is Monday, July 15th. This represents a $0.20 annualized dividend and a dividend yield of 0.25%. Arcosa’s payout ratio is 6.85%.
Analyst Ratings Changes
Separately, DA Davidson increased their price target on Arcosa from $105.00 to $110.00 and gave the company a “buy” rating in a research note on Friday, May 17th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, Arcosa has a consensus rating of “Moderate Buy” and an average target price of $93.00.
Read Our Latest Report on Arcosa
Arcosa Company Profile
Arcosa, Inc, together with its subsidiaries, provides infrastructure-related products and solutions for the construction, engineered structures, and transportation markets in the United States. It operates through three segments: Construction Products, Engineered Structures, and Transportation Products.
Read More
- Five stocks we like better than Arcosa
- What Is WallStreetBets and What Stocks Are They Targeting?
- RXO Shares Surge Following New Acquisition Deal
- 5 Top Rated Dividend Stocks to Consider
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Want to see what other hedge funds are holding ACA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arcosa, Inc. (NYSE:ACA – Free Report).
Receive News & Ratings for Arcosa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcosa and related companies with MarketBeat.com's FREE daily email newsletter.